fda

GZERO World with Ian Bremmer Podcast

How Trump is remaking US public health, with NY Times reporter Apoorva Mandavilli

Listen: President Trump has already made sweeping changes to US public health policy—from RFK Jr.’s nomination to lead the health department to withdrawing the US from the World Health Organization. On the GZERO World Podcast, New York Times science and global health reporter Apoorva Mandavilli joins Ian Bremmer for an in-depth look at health policy in the Trump administration, and what it could mean, not just for the US, but for the rest of the world.

Trump's health agenda—from RFK Jr. to leaving WHO

GZERO World with Ian Bremmer

Trump's health agenda—from RFK Jr. to leaving WHO

From RFK Jr.’s nomination to lead the health department to an executive order withdrawing the US from the World Health Organization, President Trump has already made sweeping changes to public health policy, and this may be just the beginning. On GZERO World, New York Times Science and Global Health Reporter Apoorva Mandavilli joins Ian Bremmer for an in-depth look at health and medicine in the second Trump administration—and what it could mean, not just for the US, but for the rest of the world.

NBA player sparks backlash from China; Bolsonaro's COVID negligence

NBA player sparks backlash from China; Bolsonaro's COVID negligence

China wipes Boston Celtics from NBA broadcast after the "Free Tibet" speech from Enes Kanter. Is NBA boxing itself into a corner? Brazil's Senate committee accused President Bolsonaro of crimes against humanity for COVID-19 negligence. What's happening there? FDA is set to approve the "mix and match" approach for COVID booster shots in the US. Will this deepen global vaccine inequality? Ian Bremmer shares his insights on global politics this week.

Will Joe Manchin thwart Biden's spending? FDA credibility hit

US Politics In 60 Seconds

Will Joe Manchin thwart Biden's spending? FDA credibility hit

What does the disappointing jobs number mean for the Democrats' agenda? Two top FDA vaccine regulators are about to leave this fall. How will this influence the vaccine rollout? Get insights on the latest news in US politics from Jon Lieber, head of Eurasia Group's coverage of political and policy developments in Washington, DC.

Why CIA director Bill Burns met with the Taliban

Why CIA director Bill Burns met with the Taliban

CIA director Bill Burns held a secret meeting with the leader of the Taliban. How will it impact the ongoing evacuations? What do you expect to come from the G7 emergency meeting on Afghanistan on Tuesday? With FDA approval, are vaccine mandates imminent? Ian Bremmer shares his insights on global politics.

J&J vaccine review will cause hesitancy; Blinken warns China on Taiwan

J&J vaccine review will cause hesitancy; Blinken warns China on Taiwan

Ian Bremmer shares his perspective on global politics this week on World In 60: J&J vaccine woes, Blinken warns China, Fukushima water and a large rabbit.

Should you get the J&J vaccine? Why Dr. Atul Gawande says yes

GZERO World Clips

Should you get the J&J vaccine? Why Dr. Atul Gawande says yes

On Thursday, February 4, Johnson & Johnson requested emergency FDA approval for its single-shot vaccine. In the days since the company first released efficacy and safety data, many of the headlines focused on its lower efficacy rate compared to that of mRNA vaccines from Pfizer and Moderna. But that's the wrong takeaway, says surgeon, public health expert and former member of Biden-Harris Transition COVID-19 Advisory Board, Dr. Atul Gawande. "This is a highly effective vaccine. It stops people from getting sick. If some people have some sniffles and mild effects from the coronavirus, that's okay, this is going to stop the deadly disease. And that is the ultimate goal of the vaccine." Gawande's conversation with Ian Bremmer is part of the latest episode of GZERO World, which starts airing on public television nationwide beginning this Friday, February 5th. Check local listings.